Lupin logo

LUPIN - Lupin News Story

₹1178.45 -33.8  -2.8%

Last Trade - 14/05/21

Sector
Healthcare
Size
Large Cap
Market Cap £5.18bn
Enterprise Value £5.26bn
Revenue £1.47bn
Position in Universe 82nd / 3111

BRIEF-Lupin Gets USFDA Nod For Levothyroxine Sodium Tablets

Fri 1st November, 2019 9:16am
Nov 1 (Reuters) - Lupin Ltd  LUPN.NS :
    * RECEIVES SANDA APPROVAL FROM US FDA FOR LEVOTHYROXINE
SODIUM
TABLETS USP AB

Source text for Eikon:  ID:nBSE9sMVgt 
Further company coverage:  LUPN.NS 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.